Propionyl- L -Carnitine: A Viewpoint by William R. Hiatt

ISSN： 1170-229X

Source： Drugs & Aging, Vol.12, Iss.3, 1998-03, pp. : 249-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Propionyl- L -Carnitine: A Viewpoint by Gregorio Brevetti

By Brevetti G.

Drugs & Aging, Vol. 12, Iss. 3, 1998-03 ,pp. : 250-250

Adis International

Access to resources Recommend Favorite

Propionyl- L -Carnitine

By Wiseman L.R. Brogden R.N.

Drugs & Aging, Vol. 12, Iss. 3, 1998-03 ,pp. : 243-248

Adis International

Access to resources Recommend Favorite

Effects of propionyl-l-carnitine on cardiac dysfunction in streptozotocin-diabetic rats

By Terada R. Matsubara T. Koh N. Nakamura J. Hotta N.

European Journal of Pharmacology, Vol. 357, Iss. 2, 1998-09 ,pp. : 185-191

Elsevier

Access to resources Recommend Favorite

Effect of propionyl-l-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats

By Hotta N. Koh N. Sakakibara F. Nakamura J. Hamada Y. Hara T. Fukasawa H. Kakuta H. Sakamoto N.

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

Propionyl- l -Carnitine as protector against adriamycin-induced Cardiomyopathy

By Sayed-Ahmed M.M. Salman T.M. Gaballah H.E. Abou El-Naga S.A. Nicolai R. Calvani M.

Pharmacological Research, Vol. 43, Iss. 6, 2001-06 ,pp. : 513-520

Academic Press

Access to resources Recommend Favorite